Medicine and Dentistry

1. Patient 100%
2. Neoadjuvant Chemotherapy 39%
3. Esophageal Adenocarcinoma 33%
4. Adenocarcinoma 33%
5. Esophagectomy 30%
6. Esophageal Cancer 30%
7. Cancer Surgery 25%
8. Neoplasm 24%
9. Hazard Ratio 22%
10. Surgical Margin 22%
11. Esophagus 20%
12. Quality of Life 18%
13. Lymph Node 18%
14. Analysis 13%
15. Malignant Neoplasm 13%
16. Adjuvant Therapy 13%
17. Chemotherapy 12%
18. Hospital 12%
19. Anxiety 11%
20. Health 9%
21. Neoadjuvant Therapy 8%
22. Cancer Staging 8%
23. Cohort Analysis 8%
24. Tumor Regression 7%
25. Age 7%
26. Retroperitoneal Lymph Node Dissection 7%
27. Surgical Anastomosis 7%
28. Upper Gastrointestinal Cancer 6%
29. Recurrent Disease 6%
30. Consent 6%
31. Prevalence 6%
32. Prognosis 6%
33. Proportional Hazards Model 6%
34. Morphology 6%
35. Esophageal Adenocarcinoma Cell Line 6%
36. Positron Emission Tomography-Computed Tomography 6%
37. Distress Syndrome 6%
38. Gastroesophageal Junction 6%
39. Endoscopic Ultrasound 6%
40. Systematic Review 6%
41. Overall Survival 5%
42. Therapeutic Procedure 5%